Loading organizations...
§ Private Profile · Boston, MA, USA
Tausight is a technology company.
Tausight develops cybersecurity solutions, highlighted by its Quell product, a ransomware containment platform. Quell limits encryption during an attack to minimal files, significantly reducing damage and the need for extensive data recovery. This approach intercepts ransomware at its encryption chokepoint, stopping threats without relying on signatures or behavioral patterns, and thus offers a proactive defense layer against evolving cyber threats.
Founded in 2018 by David Ting, the former CTO of Imprivata, Tausight began with an acute understanding of cybersecurity challenges within the healthcare sector. Ting's extensive background in securing Protected Health Information (PHI) revealed the critical need for a more effective ransomware containment strategy, informing the foundational work that led to the company's current offerings.
Tausight's Quell solution primarily serves IT security teams seeking robust ransomware defense across Windows endpoints. Originating from its focus on healthcare protection, the company envisions empowering organizations to withstand and recover swiftly from ransomware incidents. Tausight aims to ensure operational continuity by providing proactive containment against sophisticated cyber threats, bolstering overall cyber resilience.
Tausight has raised $32.0M across 3 funding rounds.
Tausight has raised $32.0M in total across 3 funding rounds.
Tausight has raised $32.0M in total across 3 funding rounds.
Tausight's investors include Polaris Capital, .406 Ventures, Flare Capital Partners, Polaris Partners, F-Prime Capital Partners, Jesse Hertzberg, Scott Belsky, David Barrett, Bessemer Venture Partners, Meritech Capital Partners, Mohamad Makhzoumi.
Tausight is a Boston-based cybersecurity company specializing in healthcare, offering an AI-powered security intelligence platform that protects electronic Protected Health Information (ePHI) by providing visibility, risk management, and automated protection across decentralized healthcare IT systems.[1][2][3] It serves healthcare organizations facing rising cyber threats to sensitive patient data, solving the problem of detecting, tracking, and responding to ePHI risks in complex environments through integrations with tools like Dell Technologies and CrowdStrike.[1][3] The company has shown strong growth momentum, tripling both annual recurring revenue (ARR) and its customer base in 2023, with total funding of $26M across two rounds from investors including Polaris Partners, Flare Capital Partners, .406 Ventures, and SpringRock Ventures.[1][3]
Tausight was founded in 2018 by David Ting, a healthcare security pioneer who previously served as co-founder and CTO of Imprivata, alongside leadership from healthcare executive Frank Nydam as CEO.[1][2][3] Ting launched the company with a vision to reduce healthcare-specific cyber incidents by shifting from reactive measures to a proactive, AI-driven risk management approach, addressing gaps in protecting ePHI amid growing threats.[1][3] Early traction built through strategic partnerships, such as collaborations with Dell Technologies announced in March 2024 and CrowdStrike in February 2024, which enhanced its platform's integration into healthcare security operations.[1][3]
Tausight rides the wave of escalating healthcare cyberattacks, where ePHI breaches have surged due to decentralized systems, ransomware, and regulatory pressures like HIPAA.[1][3] Its timing aligns with AI's maturation in cybersecurity and post-pandemic digitization of healthcare, amplifying demand for specialized tools amid a "cyber threat crisis."[1] Market forces favoring Tausight include healthcare's $26M funding validation and partnerships with giants like Dell and CrowdStrike, positioning it to influence ecosystem standards for patient data protection and reduce industry-wide incidents.[1][3]
Tausight is poised for accelerated expansion through deeper AI enhancements and ecosystem integrations, capitalizing on healthcare's cybersecurity spend projected to grow amid persistent threats. Trends like AI-driven threat detection and zero-trust architectures will shape its path, potentially evolving its influence from niche protector to industry-wide standard-setter. As the leader in patient data defense, Tausight exemplifies how targeted innovation fortifies healthcare's digital backbone against evolving risks.[1][3]
Tausight has raised $32.0M across 3 funding rounds. Most recently, it raised $6.0M Other Equity in August 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 15, 2023 | $6M Venture Round | Polaris Capital | .406 Ventures, Flare Capital Partners | Announced |
| Aug 1, 2023 | $6M Series U | Polaris Partners | .406 Ventures, F Prime Capital, Jesse Hertzberg, Scott Belsky, Flare Capital Partners | Announced |
| Mar 1, 2021 | $20M Series A | Flare Capital Partners, David Barrett | .406 Ventures, Bessemer Venture Partners, F Prime Capital, Meritech Capital Partners, Mohamad Makhzoumi, Polaris Partners, Jesse Hertzberg, Scott Belsky | Announced |